Your institution may have access to this item. Find your institution then sign in to continue.
Title
Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis.
Authors
Vegter, S; Tolley, K; Wilson Waterworth, T; Jones, H; Jones, S; Jewell, D
Abstract
The antisense ICAM-1 inhibitor alicaforsen has been studied in four phase 2 studies in ulcerative colitis (UC). Recruited patients varied as to the extent of their colitis and in the severity of disease at entry.